Key result
A 1% higher prevalence of the APOL1 risk genotype was associated with a 0.18 mmHg higher systolic blood pressure, translating to a 5 mmHg higher mean SBP in ethnic groups with high homozygosity rates.
Why the study?
Does higher ethnic group prevalence of APOL1 risk variants increase systolic blood pressure in African populations?
Observational (n=10,423)
Yes
Does higher ethnic group prevalence of APOL1 risk variants increase systolic blood pressure in African populations?
Mean Difference: 0.18 (95% CI 0.05–0.32)
p-value: p=<0.05
Higher prevalence of APOL1 G1/G2 homozygosity among African ethnic groups is associated with higher systolic blood pressure, highlighting a genetic predisposition to hypertension.
Should not yet change hypertension practice; leaves open causal role of APOL1 in ethnic BP disparities.
# Background Genetic variants in the Apolipoprotein L1 (APOL1) gene greatly increase risk for chronic kidney disease in African Americans. We hypothesized that the APOL1 renal risk alleles would be associated with higher blood pressure in Africans. # Methods We used data from three multi-ethnic, population-based studies from Kenya, Ghana, and Nigeria to examine the association between ethnic group prevalence of APOL1 risk variants and blood pressure. Using available genotype data, we were able to link ethnic group status to APOL1 risk variant frequency in 10 423 persons. # Results Age, sex, body mass index, and frequency of the APOL1 high-risk genotype (two risk alleles) were associated with mean systolic blood pressure (SBP). In the adjusted model, a 1% higher prevalence of the APOL1 risk genotype was associated with 0.18 mmHg (95% confidence interval CI 0.05-0.32) higher systolic blood pressure (SBP). # Conclusions Mean SBP was 5 mmHg higher in African ethnic groups where nearly a third of persons carry two high risk APOL1 alleles, compared with ethnic groups where homozygosity is rare. Since uncontrolled blood pressure predisposes to high risks for death and substantial disability prior to development of end-stage kidney disease, studies exploring the link between the APOL1 risk alleles and blood pressure are crucial to understanding the full implications of APOL1 genetic variation in Africa.
No takes yet. Share an insight, caveat, or question.
Anand et al. (2018) conducted an observational in Hypertension / APOL1 polymorphisms (n=10,423). APOL1 G1/G2 homozygosity prevalence vs. Lower prevalence of APOL1 G1/G2 homozygosity was evaluated on Mean systolic blood pressure (SBP) (0.18 mmHg per 1% higher prevalence, 95% CI 0.05-0.32, p=<0.05). A 1% higher prevalence of the APOL1 risk genotype was associated with a 0.18 mmHg higher systolic blood pressure, translating to a 5 mmHg higher mean SBP in ethnic groups with high homozygosity rates.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: